LexDanaLexDanabeta
Inventor

PETER TURECEK

Inventor
AT

Overview

5→
Patents
2021–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides20%
PatentTitleYear
12,516,083Nucleophilic catalysts for oxime linkage202611,564,992Nucleophilic catalysts for oxime linkage202311,197,916Lyophilized recombinant VWF formulations202111,191,837Recombinant VWF formulations202111,191,813Lyophilized recombinant VWF formulations2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2026Patents assigned to TAKEDA PHARMACEUTICALS CO (5)· patent assignee history
2021Patents assigned to BAXALTA INC (1)· patent assignee history
2021Patents assigned to Baxalta GmbH (1)· patent assignee history
2021–2026Based in AT· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TAKEDA PHARMACEUTICALS CO52021–2026
BAXALTA INC12021
Baxalta GmbH12021
Locations
LocationPatentsSpan
AT52021–2026